Your browser doesn't support javascript.
loading
A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
Jang, Ik-Kyung; Pettigrew, Veronica; Picard, Michael H; Kowey, Peter R; Demmel, Valentin; Zile, Michael R; Tatsuno, Jun; Wackers, Frans J Th; Hibberd, Mark.
Affiliation
  • Jang IK; Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA. ijang@partners.org
J Thromb Thrombolysis ; 20(3): 147-53, 2005 Dec.
Article in En | MEDLINE | ID: mdl-16261287
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Benzenesulfonates / Angioplasty, Balloon, Coronary / Calcium / Ventricular Function, Left / Muscle Cells / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Adult / Humans / Male / Middle aged Language: En Journal: J Thromb Thrombolysis Journal subject: ANGIOLOGIA Year: 2005 Document type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Benzenesulfonates / Angioplasty, Balloon, Coronary / Calcium / Ventricular Function, Left / Muscle Cells / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies Limits: Adolescent / Adult / Humans / Male / Middle aged Language: En Journal: J Thromb Thrombolysis Journal subject: ANGIOLOGIA Year: 2005 Document type: Article Affiliation country: United States